In the last half-hour

Who decides? How oncologists shape cancer patients’ final days Knowridge Science Report00:15

Earlier today

Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology,… Insurance News Net00:01

In the last 4 hours

Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years Medpage Today21:45 26-Mar-25

Blinatumomab Consolidation Prevents B-ALL Relapses and CAR T-Cell Therapy Consolidation May, Too OncLive21:41 26-Mar-25

In the last 6 hours

Candel Therapeutics reports positive survival data for CAN-2409 in advanced lung cancer trial Proactive Investors (Canada)20:27 26-Mar-25

Tevogen Bio CEO Named to Njbiz 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe… GlobeNewswire (Press Release)19:13 26-Mar-25

In the last 8 hours

J&J Passes AstraZeneca in Lung Cancer Drug Race — For Now (1) Bloomberg Law18:04 26-Mar-25

Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance Pharmacy Times17:34 26-Mar-25

How inherited cancer risks can be used for effective personalized therapy YaleNews16:52 26-Mar-25

Study IDs Factors Linked to Advanced Melanoma Presentation HealthDay16:52 26-Mar-25

Yesterday

Rybrevant®▼ (amivantamab) plus Lazcluze®▼ (lazertinib) demonstrates significant overall survival benefit in patients… GlobeNewswire (Press Release)15:57 26-Mar-25

Time to Full Approval for Anticancer Medicines Granted Accelerated FDA Approval Journal of American Medical Associations15:49 26-Mar-25

Phase 1 clinical trial aiming to one day transform rectal cancer into a disease treatable with… ecancer15:05 26-Mar-25

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed car T-cell… Nature.com15:04 26-Mar-25

City of Hope researchers uncover the two-step process of tumor formation News-Medical.Net14:40 26-Mar-25

FDA Approves Dual-Action Drug for Patients with Previously Treated Advanced Neuroendocrine Tumors, Backed by… Newswise (Press Release)14:07 26-Mar-25

Hope for a complete cure for hepatocellular carcinoma: Combining lenvatinib and pembrolizumab… ecancer12:53 26-Mar-25

BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025 TipRanks12:52 26-Mar-25

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping Business Wire (Press Release)12:01 26-Mar-25

Nouscom reveals promising results for lynch syndrome immunotherapy PharmaTimes11:35 26-Mar-25

Breakthrough in breast cancer care using chromosomes to monitor treatment, predict recurrence: researchers The Hindu10:26 26-Mar-25

Why vitamin B3 could help fight cancer Knowridge Science Report10:20 26-Mar-25

ImmunityBio to Host Investor Day Business Wire (Press Release)10:08 26-Mar-25

HKUMed successfully conducts the first CAR-T cell therapy in Hong Kong for end-stage multiple myeloma using an advanced … HKU Li Ka Shing Faculty of Medicine (Press Release)09:46 26-Mar-25

Cancer Immunotherapy Market: Growth Prospects, Key Players, and Regional Insights Industry Today09:34 26-Mar-25

Tract Bio identifies drug targets for oesophageal cancer Drug Target Review09:10 26-Mar-25

Daiichi Sankyo aims to launch 5 ADC therapies in Korea by 2030 Korea Biomedical Review07:17 26-Mar-25

AstraZeneca showcases Tagrisso's expanding role in EGFR-mutant lung cancer at ELCC 2025 Korea Biomedical Review07:06 26-Mar-25

In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high… Nature.com02:39 26-Mar-25

First pathological complete response reported for Yuhan’s Leclaza Korea Biomedical Review02:20 26-Mar-25

High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis Hospimedica02:19 26-Mar-25

KMC to provide free cervical cancer screening, treatment at its health clinics The Kathmandu Post01:22 26-Mar-25

Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant… Nature.com00:27 26-Mar-25

In the last 7 days

Mural Oncology sinks on nemvaleukin miss in ovarian cancer BioWorld21:56 25-Mar-25

KaliVir Immunotherapeutics Announces Details of Presentation at 2025 American Association for… Business Wire (Press Release)20:53 25-Mar-25

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025 Business Wire (Press Release)20:43 25-Mar-25

Oric® Pharmaceuticals Announces Oric-944 Preclinical Presentation at the 2025 American Association for Cancer Research… GlobeNewswire (Press Release)20:39 25-Mar-25

I've had 180 rounds of chemo... tragic reason I'm giving up after 10-year fight with 'death… MailOnline20:35 25-Mar-25

Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant… PR Newswire (Press Release)20:33 25-Mar-25

New Tuberculosis Vaccine Shows Promise to Treat Bladder Cancer Discover Magazine20:04 25-Mar-25

Lupus-Related Antibody Shows Promise in Enhancing Cancer Treatment Efficacy Newswise (Press Release)18:15 25-Mar-25

New insights into therapy resistance in breast cancer News-Medical.Net17:36 25-Mar-25

Why Is it Important to Choose a Pediatric Research Hospital With Access to Clinical Trials? Newswise (Press Release)17:24 25-Mar-25

New trial aims to make rectal cancer more responsive to radiation News-Medical.Net17:16 25-Mar-25

Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization … GlobeNewswire (Press Release)17:13 25-Mar-25

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in… ecancer16:23 25-Mar-25

Ocular Adverse Events From Mirvetuximab Soravtansine Not Associated With HRQoL Impact in FRα+ Ovarian Cancer American Journal of Managed Care16:13 25-Mar-25

New tool to boost cancer immunotherapy effects ecancer15:52 25-Mar-25

Chris Stark's testicular cancer diagnosis – the key symptoms to check for and treatment options My London15:03 25-Mar-25

The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in… Nature.com13:30 25-Mar-25

Targeted Treatment and Improved Radiation Technologies Offer Advantages in CRC Realm OncLive13:19 25-Mar-25

Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and Il-2, Highlights Findings at Swcr … GlobeNewswire (Press Release)13:10 25-Mar-25

Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancer Clinical Trials Arena13:07 25-Mar-25

City of Hope Opens Phase 1 Clinical Trial Aiming to One Day Transform Rectal Cancer Into a… Business Wire (Press Release)13:06 25-Mar-25

3 DDR Phenotypes May Predict Chemotherapy Response in SCLC American Journal of Managed Care13:00 25-Mar-25

Verdi Grants Anixa 6-month Right To Negotiate Transaction For Development Of Verdi's Cancer Vaccines RTT News12:49 25-Mar-25

First Patient Dosed in Immutep’s Tacti-004 Phase III Trial in First Line Non-Small Cell Lung Cancer GlobeNewswire (Press Release)12:09 25-Mar-25

OS Therapies’ OST-HER2 Immunotherapy for Osteosarcoma Featured in Upcoming Movie Shelter Me:… Business Wire (Press Release)11:42 25-Mar-25

Why DNA Damage Response deserves renewed focus in cancer therapy Drug Target Review11:22 25-Mar-25

FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatment Clinical Trials Arena11:06 25-Mar-25

Sermonix and Regor to enhance breast cancer treatment options Pharmaceutical Technology10:30 25-Mar-25

Novel radioactive drug targets aggressive metastatic melanoma Drug Target Review09:06 25-Mar-25

ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized… Nature.com08:26 25-Mar-25

AbbVie and Genmab: Can a legal battle break a billion-dollar bond? Labiotech08:09 25-Mar-25

Scientists secure funding to further develop novel precision therapies against major drivers of cancer University of Glasgow07:20 25-Mar-25

WA community rallies to save teen battling rare cancer The West Australian05:19 25-Mar-25

Spectrum of presentation of intraocular metastases from cutaneous melanoma in the era of immunotherapy and targeted… Nature.com04:21 25-Mar-25

Characterization of pritumumab in murine models and primate safety study Nature.com02:05 25-Mar-25

Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors News-Medical.Net01:20 25-Mar-25

Vyloy pioneers new era in metastatic gastric cancer treatment with Claudin 18.2 targeting Korea Biomedical Review00:49 25-Mar-25

Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out Law36000:29 25-Mar-25

Reduced Radiotherapy Margins Yield Outcomes Comparable With Standard Margins in HGG OncLive22:23 24-Mar-25

New Surgery for Prostate Cancer Could Reduce Some Unwanted Side Effects Discover Magazine21:15 24-Mar-25

Moffitt Study Finds New Immunotherapy Strategy for Enhancing Melanoma Treatment OncLive17:17 24-Mar-25

Elevating Cancer Care Through Personalized Treatment American Journal of Managed Care17:11 24-Mar-25

Simple urine test may spare kidney cancer patients from invasive scans News-Medical.Net16:30 24-Mar-25

Innovent Biologics doses first subject in trial of ovarian cancer therapy Clinical Trials Arena16:28 24-Mar-25

HLI makes $1m prostate cancer prevention pledge to each member Longevity Technology15:58 24-Mar-25

Why brain metastases of breast cancer resist a promising candidate therapy Newswise (Press Release)15:38 24-Mar-25

Survival Benefit in Metastatic CRPC Study Spurs Questions on Patient Selection Medpage Today15:29 24-Mar-25

NMPA Approves sNDA for Toripalimab Plus Bevacizumab in Advanced HCC OncLive15:05 24-Mar-25

Researchers on the STAMPEDE trial awarded first-ever NIHR Impact Prize for life-changing work The Royal Marsden NHS Foundation Trust (Press Release)15:04 24-Mar-25

New technique doubles erectile function preservation in prostate surgery News-Medical.Net14:29 24-Mar-25

Magnetic nanoparticles transport drugs deep into tumors to slow cancer growth Phys.org14:11 24-Mar-25

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach Labiotech14:10 24-Mar-25

Eurycomalactone switched hepatocellular carcinoma cells into quiescence through 5’tRFAla/Dvl/β-catenin pathway… Nature.com12:52 24-Mar-25

Cali rings the bell to mark the end of cancer treatment Lewisham and Greenwich NHS Trust (Press Release)12:33 24-Mar-25

Avoiding prostate cancer screening can have dire consequences. Here's why The Week12:29 24-Mar-25

Vicero Welcomes Renowned Cancer Immunotherapy Experts to its Scientific Advisory Board Business Wire (Press Release)12:08 24-Mar-25

Imunon Finalizes Phase 3 Study Design with FDA for Imnn-001 in Newly Diagnosed Advanced Ovarian Cancer GlobeNewswire (Press Release)12:05 24-Mar-25

A new treatment may prevent the spread of cancer cells, ASU and UA researchers say KJZZ12:05 24-Mar-25

FDA approves IND application for Everest’s cancer vaccine Pharmaceutical Technology11:38 24-Mar-25

Nanotechnology innovation aims to improve breast cancer treatment News-Medical.Net11:16 24-Mar-25

Micro-ultrasound proves as effective as MRI in prostate cancer diagnosis News-Medical.Net11:06 24-Mar-25

First subject enrolled in MUSC Hollings’ Phase II/III trial of HNSCC treatment Clinical Trials Arena11:03 24-Mar-25

EAU 2025: Twice as many men recover erectile function after improved prostate cancer surgery ecancer10:53 24-Mar-25

EAU 2025: High resolution ultrasound could enable faster prostate cancer diagnosis ecancer10:53 24-Mar-25

Twice as many men recover erectile function after improved prostate cancer surgery ecancer10:43 24-Mar-25

EAU 2025: Urine test could halve post-op scans for kidney cancer ecancer10:32 24-Mar-25

Exploiting Hla-Dr mismatches for car therapy in acute myeloid leukemia Nature.com10:30 24-Mar-25

AI recognition of cell shape could revolutionise drug development British Society for Haematology09:12 24-Mar-25

New research offers hope for high-grade glioma treatment Drug Target Review09:11 24-Mar-25

Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual … Nature.com09:01 24-Mar-25

Nanotechnology breakthrough may boost treatment for aggressive breast cancer: Study DD News05:34 24-Mar-25

Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology Nature.com03:53 24-Mar-25

Intranasal prime-boost RNA vaccination elicits potent T cell response for lung cancer therapy Nature.com00:40 24-Mar-25

Game-Changer In Cancer Care: Mobile Imaging Brings Gallium-68 Dotatate PET-CT Scans To Patients Scoop00:29 24-Mar-25

Conference on EBUS and advanced lung cancer treatments organised in Hyderabad The Hindu13:46 23-Mar-25

Scientist whose work led FDA To ban food dye says agency overstated risk The Columbian, Washington13:09 23-Mar-25

Physical Functioning Measures May Predict Survival Outcomes, ICANS Risk With CAR T-Cell Therapy in NHL OncLive10:14 23-Mar-25

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for… Nature.com09:37 23-Mar-25

Antiepileptic drugs failed to prevent initial seizures or improve survival outcomes in patients with primary CNS… Nature.com09:37 23-Mar-25

New insights into T cell metabolism in liver cancer: from mechanism to therapy Nature.com07:32 23-Mar-25

Symposium on colon cancer trains focus on early diagnosis The Hindu17:15 22-Mar-25

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS… ecancer11:22 22-Mar-25

view more headlines

27 Mar 00:15

About our Cancer Treatment news

Latest news on Cancer Treatment including updates on radiotherapy, chemotherapy, immunotherapy, funding, trials and developments.

Cancer Treatment

Latest News

About our Cancer Treatment news

Cancer Top Stories

Health Top Stories

UK Top Stories

World Top Stories